ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Surprisingly, as observed in the results, this microRNA had the highest expression in some CML patients treated with Imatinib and with a high percentage of BCR::ABL1, while other patients in this same group presented values similar to the average of controls.